Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.36 CAD | -1.09% | -2.85% | +31.09% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 214.1 | 225 | 530.5 | 673.5 | - | - |
Enterprise Value (EV) 1 | 196.3 | 433.3 | 530.5 | 832.5 | 763.7 | 607.8 |
P/E ratio | 8.61 x | 19.4 x | 4.55 x | 56.9 x | 133 x | - |
Yield | 7.24% | 8% | - | 4.19% | 3.51% | 4.24% |
Capitalization / Revenue | 2.62 x | 2.42 x | 3.19 x | 4.08 x | 3.9 x | 3.53 x |
EV / Revenue | 2.4 x | 4.66 x | 3.19 x | 5.05 x | 4.42 x | 3.19 x |
EV / EBITDA | 1.95 x | 5.26 x | 4.69 x | 5.38 x | 5.24 x | 3.8 x |
EV / FCF | 2.14 x | -2.21 x | - | 7.84 x | 7.35 x | 6.48 x |
FCF Yield | 46.8% | -45.3% | - | 12.8% | 13.6% | 15.4% |
Price to Book | 0.55 x | 0.59 x | - | 1.13 x | 1.04 x | 0.88 x |
Nbr of stocks (in thousands) | 40,107 | 38,666 | 56,358 | 56,358 | - | - |
Reference price 2 | 5.339 | 5.819 | 9.414 | 11.95 | 11.95 | 11.95 |
Announcement Date | 3/7/22 | 3/1/23 | 2/28/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 81.76 | 93.03 | 166.3 | 164.9 | 172.9 | 190.6 |
EBITDA 1 | - | 100.6 | 82.44 | 113.2 | 154.6 | 145.6 | 159.8 |
EBIT 1 | - | 58.79 | 23.17 | 26.13 | 45 | - | - |
Operating Margin | - | 71.9% | 24.91% | 15.72% | 27.29% | - | - |
Earnings before Tax (EBT) 1 | - | - | - | 92.3 | 24 | - | - |
Net income 1 | -0.00036 | 21.56 | 11.6 | 92.3 | 24.68 | 42.67 | 54.6 |
Net margin | - | 26.37% | 12.47% | 55.51% | 14.96% | 24.68% | 28.65% |
EPS 2 | - | 0.6200 | 0.3000 | 2.070 | 0.2100 | 0.0900 | - |
Free Cash Flow 1 | - | 91.86 | -196.2 | - | 106.2 | 103.9 | 93.85 |
FCF margin | - | 112.35% | -210.89% | - | 64.4% | 60.12% | 49.25% |
FCF Conversion (EBITDA) | - | 91.29% | - | - | 68.69% | 71.37% | 58.72% |
FCF Conversion (Net income) | - | 426.03% | - | - | 430.4% | 243.61% | 171.89% |
Dividend per Share 2 | - | 0.3867 | 0.4655 | - | 0.5009 | 0.4198 | 0.5069 |
Announcement Date | 2/10/21 | 3/7/22 | 3/1/23 | 2/28/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 22.86 | 22.21 | 22.62 | 21.3 | 26.47 | 22.64 | 28.24 | 28.06 | 34.14 | 75.84 | 38.12 | 41.96 | 42.91 | 44.22 | 42.4 |
EBITDA 1 | 12.41 | 31.97 | 17.81 | 21.44 | 15.81 | 27.37 | 21.43 | 25.07 | 20.25 | 46.45 | 52.6 | 31.46 | 35.51 | 38.33 | 33.75 |
EBIT | 1.288 | 19.06 | 5.036 | 8.022 | 1.822 | - | 2.266 | 5.471 | - | - | - | - | - | - | - |
Operating Margin | 5.63% | 85.78% | 22.26% | 37.67% | 6.88% | - | 8.03% | 19.5% | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | 75.03 | - | 22.18 | - | - | - | - | - |
Net income 1 | - | 3.362 | - | 3.097 | 7.614 | -4.807 | -1.123 | 75.03 | -3.781 | 22.18 | 6.467 | 2.333 | 6.267 | 9.867 | 12.7 |
Net margin | - | 15.13% | - | 14.54% | 28.76% | -21.23% | -3.98% | 267.42% | -11.07% | 29.24% | 16.96% | 5.56% | 14.6% | 22.31% | 29.95% |
EPS | 0.1900 | 0.0800 | 0.1500 | 0.0800 | 0.2000 | -0.1300 | -0.0300 | 2.000 | -0.0800 | 0.3900 | - | - | - | - | - |
Dividend per Share 2 | 0.0375 | 0.2950 | 0.0750 | 0.0750 | 0.0750 | - | 0.5405 | 0.0750 | - | - | 0.1761 | 0.0425 | 0.0425 | 0.2352 | - |
Announcement Date | 11/8/21 | 3/7/22 | 5/10/22 | 8/3/22 | 11/7/22 | 3/1/23 | 5/11/23 | 8/14/23 | 11/13/23 | 2/28/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | 208 | - | 159 | 90.2 | - |
Net Cash position 1 | - | 17.8 | - | - | - | - | 65.8 |
Leverage (Debt/EBITDA) | - | - | 2.527 x | - | 1.028 x | 0.6194 x | - |
Free Cash Flow 1 | - | 91.9 | -196 | - | 106 | 104 | 93.9 |
ROE (net income / shareholders' equity) | - | 33.8% | 19.2% | - | 21.6% | 21.8% | 21% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | 9.700 | 9.850 | - | 10.60 | 11.50 | 13.60 |
Cash Flow per Share 2 | - | 2.650 | 2.010 | - | 3.320 | - | - |
Capex 1 | - | - | 274 | - | 178 | - | - |
Capex / Sales | - | - | 294.16% | - | 107.85% | - | - |
Announcement Date | 2/10/21 | 3/7/22 | 3/1/23 | 2/28/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.09% | 674M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- DHT.U Stock
- Financials DRI Healthcare Trust